◆ TICKERBASE · US STOCK FINANCIAL DATA LIBRARY

HomeAll stocks › JAZZ

Jazz Pharmaceuticals plc (JAZZ) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Biotechnology · DATA UPDATED 2026-07-09

Jazz Pharmaceuticals plc (JAZZ) operates in the Biotechnology industry and is headquartered in Dublin, Ireland with about 2,890 employees. Its market capitalization is roughly $16 billion. In the fiscal year ended 2025-12-31, JAZZ reported $4.3B in revenue and ($356M) in net income.

Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally.

Interactive charts & full statements → Open the JAZZ valuation workbench →

JAZZ Revenue & Earnings History — Annual Income Statement

Income statement2025-12-312024-12-312023-12-312022-12-312021-12-31
Total Revenue$4.3B$4.1B$3.8B$3.7B
Gross Profit$3.8B$3.6B$3.4B$3.1B
Operating Income (EBIT)$518M$727M$598M$512M
Net Income($356M)$560M$415M($224M)

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

JAZZ Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement2026-03-312025-12-312025-09-302025-06-302025-03-312024-12-31
Total Revenue$1.1B$1.2B$1.1B$1.0B$898M
Gross Profit$935M$1.0B$997M$929M$793M
Operating Income (EBIT)$337M$254M$100M$219M($56M)
Net Income$293M$204M$251M($718M)($92M)

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

JAZZ Free Cash Flow History

JAZZ Balance Sheet History

Balance sheet2025-12-312024-12-312023-12-312022-12-312021-12-31
Total Assets$11.7B$12.0B$11.4B$10.8B
Total Liabilities$7.3B$7.9B$7.7B$7.7B

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive JAZZ viewer.

Other Companies in Biotechnology

← JATTAll stocksJBDI →

About TickerBase · Data methodology & sources

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.